Skip to main content

ACTION: Improving breast cancer treatment adherence

For many reasons (e.g. side effects, treatment beliefs), women with breast cancer struggle to adhere to adjuvant (post-treatment) hormonal therapy (HT). This is problematic because non-adherence increases risk of mortality. 

In this programme we will co-develop, with women taking HTs and NHS clinicians, a brief psychological intervention that will be delivered to women with breast cancer after they have finished their active cancer treatment. This intervention aims to improve adherence to HTs and improve quality of life. 

There will then be a small preliminary trial of this intervention to see whether it should be tested further in a larger definitive trial.

Lead researcher

Dr Samuel Smith

Cancer Research UK Postdoctoral Fellow, Queen Mary University of London

Dr Christopher Graham

University Academic Fellow in Behavioural Medicine & Clinical Psychologist, Queen's University Belfast

Every 17 minutes someone is diagnosed with cancer in Yorkshire

Our aim is for more people to survive cancer, here in Yorkshire and beyond.

Please help us continue to fund life-saving research.